A French lesson. French experience shows full funding of treatment advances saves money. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

J Int Assoc Physicians AIDS Care. 1997 Apr;3(4):49. Unique Identifier : AIDSLINE AIDS/97702492
Alcorn K

Abstract: France's HIV treatment expenditures, the highest in Europe and second only to the United States, have created evidence of the real-life cost-effectiveness of triple combination antiretroviral therapy. The French have demonstrated that savings in treatment costs can be obtained with early and intensive antiretroviral therapy. Based on such findings, the French Ministry of Health projects a 20 percent reduction in hospitalization, a 30 percent reduction in deaths, and a reduction in new AIDS cases in 1997. Italy and England are, by comparison, having problems developing a standard of HIV care and finding funding to support antiretroviral therapy.

Keywords: Anti-HIV Agents/ADMINISTRATION & DOSAGE/ECONOMICS/*THERAPEUTIC USE Drug Costs Drug Therapy, Combination Financing, Government France HIV Infections/*DRUG THERAPY HIV Protease Inhibitors/ADMINISTRATION & DOSAGE/ECONOMICS/ THERAPEUTIC USE Human Reverse Transcriptase Inhibitors/ADMINISTRATION & DOSAGE/ ECONOMICS/THERAPEUTIC USE NEWSLETTER ARTICLE
970830
M9781257

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .